ruxolitinib
Targeted Therapies
Common brand names
- Jakafi
- Jakavi
- Opzelura
Approved use in
- Chronic Eosinophilic Leukemia
- Chronic Myelomonocytic Leukemia
- Chronic Neutrophilic Leukemia
- Cutaneous T-Cell Lymphoma
- Essential Thrombocythemia
- Large Granular Lymphocytic Leukemia
- Myelofibrosis
- Polycythemia Vera
- T-Cell Prolymphocytic Leukemia
Information about use in Chronic Neutrophilic Leukemia
Information about use in Blood Cancer
Information about use in Myelofibrosis
Information about use in Chronic Eosinophilic Leukemia
Information about use in Chronic Myelomonocytic Leukemia
Information about use in Cutaneous T-Cell Lymphoma
Information about use in Essential Thrombocythemia
Information about use in Large Granular Lymphocytic Leukemia
Information about use in Polycythemia Vera
Information about use in T-Cell Prolymphocytic Leukemia